Search

Drazen Ostovic

age ~65

from Redwood City, CA

Also known as:
  • Drazen B
  • Stevic O Drazen
  • Drazen C

Drazen Ostovic Phones & Addresses

  • Redwood City, CA
  • 762 Bounty Dr, San Mateo, CA 94404
  • Foster City, CA
  • 582 Camino Del Sol, Newbury Park, CA 91320
  • Thousand Oaks, CA
  • 2509 Long Meadow Rd, Lansdale, PA 19446
  • Hatfield, PA
  • Ventura, CA
  • Montgomery, PA

Work

  • Company:
    Ko pharm r&d, llc., pharmaceutical r&d consulting company
    Oct 2011 to 2012
  • Address:
    California
  • Position:
    President, preclinical and early clinical pharm r&d

Education

  • Degree:
    Postdoc
  • School / High School:
    University of California, Santa Barbara
    1986 to 1989
  • Specialities:
    Physical Bioorganic Chemistry

Languages

English • Croatian

Industries

Pharmaceuticals

Us Patents

  • Dry Granulation Formulation For An Hiv Protease Inhibitor

    view source
  • US Patent:
    6645961, Nov 11, 2003
  • Filed:
    Mar 4, 1998
  • Appl. No.:
    09/045885
  • Inventors:
    Chung Y. Lui - Lansdale PA
    Drazen Ostovic - Lansdale PA
    Ashok V. Katdare - Norristown PA
    Christine Stelmach - Tinton Falls NJ
  • Assignee:
    Merck Co., Inc. - Rahway NJ
  • International Classification:
    A61K 31535
  • US Classification:
    5142315, 514252, 514255, 514311
  • Abstract:
    This invention relates to a dry granulation capsule formulation of the HIV protease inhibitor, indinavir sulfate, which is useful in the treatment of AIDS, ARC or HIV infection. Processes for making the oral formulation are also disclosed.
  • Pharmaceutical Compositions Containing An Hiv Integrase Inhibitor And A Nonionic Surfactant

    view source
  • US Patent:
    2005016, Jul 28, 2005
  • Filed:
    Mar 13, 2003
  • Appl. No.:
    10/509213
  • Inventors:
    Sandra Robertson - Harleysville PA,
    Maria Cruanes - Lansdale PA,
    Sami karaborni - Lansdale PA,
    Drazen Ostovic - Newbury Park CA,
    Ashkan Kamali - Ask West Conshohacken PA,
    Santipharp Panmai - North Wales PA,
  • International Classification:
    A61K031/541
    A61K031/5377
    A61K031/496
    A61K031/4745
    A61K009/48
    A61K009/20
  • US Classification:
    514210210, 514233800, 514300000, 514227800, 514253040, 424451000, 424464000
  • Abstract:
    Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a nonionic surfactant; wherein R, R, Rand Qare defined herein. Compounds of Formula (I) are HIV integrase inhibitors, and the pharmaceutical compositions are useful for preventing or treating HIV infection or for preventing, treating, or delaying the onset of AIDS. The pharmaceutical compositions are typically administered orally, for example, in the form of capsules or tablets, and can provide good oral bioavailability. Methods for preparing encapsulated and tabletted forms of the pharmaceutical compositions are described.
  • Process For Preparing Stabilized Vitamin D

    view source
  • US Patent:
    2006001, Jan 26, 2006
  • Filed:
    Jul 7, 2005
  • Appl. No.:
    11/176610
  • Inventors:
    David Boardman - Norristown PA,
    Shyam Karki - Lansdale PA,
    Aquiles Leyes - Schwenksville PA,
    Drazen Ostovic - Newbury Park CA,
  • International Classification:
    A61K 31/59
  • US Classification:
    514167000
  • Abstract:
    This invention is related to a process for preparing a stabilized form of vitamin D which comprises the steps of: a) dissolving vitamin D in a solution that contains water and at least one surfactant to produce a mixture; b) spraying the mixture onto an inert carrier to produce a wet mass; and c) drying the wet mass obtain the stabilized form of vitamin D.
  • Liquid And Semi-Solid Pharmaceutical Formulations For Oral Administration Of A Substituted Amide

    view source
  • US Patent:
    2007029, Dec 27, 2007
  • Filed:
    Nov 18, 2005
  • Appl. No.:
    11/667344
  • Inventors:
    Andrey Peresypkin - Cranford NJ,
    Eleni Dokou - Harleysville PA,
    Craig McKelvey - Ambler PA,
    Charles DeLuca - Royersford PA,
    Laman Alani - Lansdale PA,
    Todd Gibson - North Haven CT,
    Danielle Euler - Souderton PA,
    Santipharp Panmai - West Point PA,
    W. Wuelfing - Schwenksville PA,
    Thomas Gandek - Collegeville PA,
    Drazen Ostovic - Newbury Park CA,
    Timothy Rhodes - South Orange NJ,
    Brian Hamilton - Lansdale PA,
  • International Classification:
    A61K 9/48
    A61K 31/44
    A61P 25/30
    A61P 3/04
    A61P 3/10
  • US Classification:
    424456000, 514351000
  • Abstract:
    N-[1S,2S]-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-trifluoromethyl]pyridine-2-yl}oxy}propanamide (Compound I) has surprisingly improved solubility and bioavailability in a lipophilic vehicle comprising a pharmaceutically acceptable digestible oil, a surfactant, or a cosolvent, or a mixture of any two or more thereof. In one embodiment of the present invention are self-emulsifying or self-microemulsifying composition comprising 1) Compound I; 2) a surfactant having an HLB of 1 to 8; and 3) a surfactant having an HLB of over 8 to 20; and optionally, 4) a digestible oil and/or cosolvent and/or antioxidant or preservative.
  • Sorbic Acid Analog Co-Crystals

    view source
  • US Patent:
    2008005, Feb 28, 2008
  • Filed:
    Aug 22, 2007
  • Appl. No.:
    11/895071
  • Inventors:
    Annette Bak - Watertown MA,
    Drazen Ostovic - Newbury Park CA,
  • International Classification:
    A61K 31/19
    C07C 57/03
    C07C 57/10
  • US Classification:
    514557, 562598, 562601
  • Abstract:
    The present invention relates to a pharmaceutical co-crystal comprising an active pharmaceutical ingredient and a co-crystal agent having the structure R—C(═O)XH.
  • Anhydrous Alendronate Monosodium Salt Formulations

    view source
  • US Patent:
    6008207, Dec 28, 1999
  • Filed:
    Aug 13, 1998
  • Appl. No.:
    9/133200
  • Inventors:
    Gerald S. Brenner - Norristown PA
    Drazen Ostovic - Lansdale PA
    Earl R. Oberholtzer - Hatfield PA
    J. Eric Thies - Scotch Plains NJ
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 3166
  • US Classification:
    514108
  • Abstract:
    Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical doage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
  • Anhydrous Alendronate Monosodium Salt Formulations

    view source
  • US Patent:
    5849726, Dec 15, 1998
  • Filed:
    Dec 3, 1997
  • Appl. No.:
    8/973386
  • Inventors:
    Gerald S. Brenner - Norristown PA
    Drazen Ostovic - Lansdale PA
    Earl R. Oberholtzer - Hatfield PA
    J. Eric Thies - Scotch Plains NJ
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 3166
  • US Classification:
    514108
  • Abstract:
    Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical dosage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.

Resumes

Drazen Ostovic Photo 1

Pharmaceutical R&Amp;D Consultant

view source
Position:
President, Preclinical and Early Clinical Pharm R&D at KO Pharm R&D, LLC., Pharmaceutical R&D Consulting Company
Location:
Greater Los Angeles Area
Industry:
Pharmaceuticals
Work:
KO Pharm R&D, LLC., Pharmaceutical R&D Consulting Company - California since Oct 2011
President, Preclinical and Early Clinical Pharm R&D

Amgen - California Mar 2004 - Dec 2011
Executive Director

Merck - West Point, PA Jan 1989 - Mar 2004
Director

Theravance - South San Francisco, CA 1999 - 2001
Associate Director
Education:
University of California, Santa Barbara 1986 - 1989
Postdoc, Physical Bioorganic Chemistry
University of Minnesota-Twin Cities 1980 - 1985
Ph.D., Physical Organic Chemistry
University of Zagreb 1975 - 1979
Pharmaceutical Engineer, Pharmacy
Languages:
English
Croatian
Name / Title
Company / Classification
Phones & Addresses
Drazen Ostovic
Ko Pharm R&D, LLC
Consulting for Scientific Companies
582 Camino Del Sol, Thousand Oaks, CA 91320
19700 Fairchild, Irvine, CA 92612
1222 Dewey St, Redwood City, CA 94061

Facebook

Drazen Ostovic Photo 2

Drazen Ostovic

view source
Friends:
Greg Fancher, Atif Zaheer Farooqi, Marisol Rodriguez-Price, Maria Ostovic
Drazen Ostovic Photo 3

Drazen Ostovic

view source

Googleplus

Drazen Ostovic Photo 4

Drazen Ostovic


Get Report for Drazen Ostovic from Redwood City, CA, age ~65
Control profile